Zosano Pharma Stock News

The global cluster headache market is estimated to be valued at US$ 355.2 Million in 2021 and is expected to increase to US$ 550.1 Million by 2028, witnessing a CAGR of 6.4% over the forecast period (2021-2028). Cluster headache is one

FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System Zosano Pharma Corporation (NASDAQ: ZSAN) surged over 35% in premarket trading after announcing the successful formulation of a COVID-19 vaccine candidate on its microneedle patch The post The Buzz Show: Zosano Pharma (NASDAQ: ZSAN) COVID-19 Vaccine Candidate on its Microneedle Patch first appeared on Financial Buzz .

FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation of a COVID-19 vaccine candidate, obtained from a vaccine developer, utilizing Zosanos microneedle patch system. Zosanos patch consists of an array of approximately two thousand drug-coated titanium microneedles mounted on an adhesive patch that is administered to the skin using a reusable applicator.

Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! The post Today's Hot Penny Stocks: What's Moving ZSAN, AVGR

Zosano Pharma Corporation (ZSAN) with the stream of -3.09% also noticed, India InVivo Therapeutics Holdings Corp. (NVIV) encountered a rapid change of -0.02% in the last hour of Tuesdays trading The post Up to Date Stock in Review: Zosano Pharma Corporation (NASDAQ:ZSAN), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) appeared first on Stocks Equity .

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -10.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the

FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended S

The stock price of Zosano Pharma Corp (NASDAQ: ZSAN) increased by over 40% pre-market today. This is why it happened.

FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has been granted a Type C written r

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer,

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -30.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stoc

Penny stocks are a great entry into the market. Here are seven that have the potential to provide quick returns with their strong catalysts.

FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent c

These three biotech penny stocks all have developed drugs that have shown strong indications of success. The post 3 Biopharma Penny Stocks That Could be Millionaire Makers appeared first on InvestorPl

ZSAN stock is zooming higher on Thursday after Zosano Pharma shared positive data on its proprietary migraine treatment. The post ZSAN Stock: Why Zosano Pharma Is Racing Higher Today appeared first on